Related Experiment Videos
The present and future of radiolabelled antibodies in oncology
1St Bartholomews Hospital Medical College, London, England.
Annals of Nuclear Medicine
|August 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.
European journal of nuclear medicine and molecular imaging·2008
Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004
Radioimmunoscintigraphy with Tc-99m-labelled SM3 in differentiating malignant from benign adnexal masses.
BJOG : an international journal of obstetrics and gynaecology·2003
Neuro-otological findings in Pendred syndrome.
International journal of audiology·2003
123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases.
Nuclear medicine communications·2003
Energy-specific attenuation and half-value layers of BaSO4-loaded rubber for Lu-177 gamma-ray shielding.
Annals of nuclear medicine·2026
The value of fibroblast activation protein inhibitor-based radionuclide theranostics in sarcoma: a systematic review.
Annals of nuclear medicine·2026
An institutional experience of a scripting-driven automation of the emergent palliative radiotherapy workflow.
Journal of applied clinical medical physics·2026
Volumetric Modulated Arc Therapy for lung cancer: Correlation between dose and volume.
Journal of applied clinical medical physics·2026
The "Scintigraphic Flip": A Visual Warning Sign of Impending Hematologic Toxicity.
Clinical nuclear medicine·2026
A multicenter analysis of prognostic factors for patients undergoing re-irradiation for recurrent glioblastoma.
Neuro-oncology advances·2026